The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.25651787
   PubMed Web of Science ®Google Scholar
• Arbyn M, Roelens J, Simoens C, et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev. 2013;3:CD008054.
   Google Scholar
• Wright T, Cox J, Massad L, et al. ASCCP Sponsored Consensus Conference. Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120–2129.11966387
   PubMed Web of Science ®Google Scholar
• Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical cancer, version 3. 2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:64–84.30659131
   PubMed Web of Science ®Google Scholar
• Cox JT. Management of women with cervical cytology interpreted as ASC-US or as ASC-H. Clin Obstet Gynecol. 2005;48:160–177.15725868
   PubMed Web of Science ®Google Scholar
• Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–2119.11966386
   PubMed Web of Science ®Google Scholar
• Perkins Rebecca B, Guido Richard S, Castle Philip E, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24:102–131.32243307
   PubMed Web of Science ®Google Scholar
• Cuzick J, Myers O, Lee JH, et al. Outcomes in women with cytology showing atypical squamous cells of undetermined significance with vs without human papillomavirus testing. JAMA Oncol. 2017;3:1327–1334.28655061
   PubMed Web of Science ®Google Scholar
• Kyrgiou M, Kalliala IE, Mitra A, et al. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test. Cochrane Database Syst Rev. 2017;1:CD009836.28125861
   PubMed Web of Science ®Google Scholar
• Katki HA, Schiffman M, Castle PE, et al. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Low Genit Tract Dis. 2013;17:S28–S35.23519302
   PubMed Web of Science ®Google Scholar
• Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001;286:3106–3114.11754676
   PubMed Web of Science ®Google Scholar
• Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999;354:20–25.10406360
   PubMed Web of Science ®Google Scholar
• Meijer CJLM, Snijders PJF. Human papillomavirus triage of women with atypical squamous cells of undetermined significance-reduction of overtreatment needed. JAMA. 2017;3:1310–1311.
   Google Scholar
• Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009;10:321–322.19350698
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–1056.20952254
   PubMed Web of Science ®Google Scholar
• Kjær SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102:1478–1488.20841605
   PubMedGoogle Scholar
• Lee S, Kim JW, Hong JH, et al. Clinical significance of HPV DNA cotesting in Korean women with ASCUS or ASC-H. Diagn Cytopathol. 2014;42:1058–1062.24825374
   PubMed Web of Science ®Google Scholar
• Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147–172.22422631
   PubMed Web of Science ®Google Scholar
• Lin CQ, Cui JF, Zhang X, et al. Human papillomavirus genotyping to predict the risk of cervical precancerous lesions or cancer in women with minor abnormal cytology in China. Acta Cytol. 2015;59:405–411.26565687
   PubMedGoogle Scholar
• Guo Z, Jia MM, Chen Q, et al. Performance of different combination models of high-risk HPV genotyping in triaging chinese women with atypical squamous cells of undetermined significance. Front Oncol. 2019;9:902.31616628
   PubMed Web of Science ®Google Scholar
• Zheng B, Yang H, Li Z, et al. Atypical squamous cells of undetermined significance cervical cytology report rate and histologic follow-up findings from the largest College of American Pathologists-Certified Laboratory in China. Arch Pathol Lab Med. 2019;143:748–752.30605022
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Henson DE, Herbst AL, et al. Interim guidelines for management of abnormal cervical cytology. The 1992 national cancer institute workshop. JAMA. 1994;271:1866–1869.8196145
   PubMed Web of Science ®Google Scholar
• Risley C, Clarke MA, Geisinger KR, et al. Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix. Cancer Cytopathol. 2020.
   Web of Science ®Google Scholar
• Hashim D, Engesæter B, Baadstrand Skare G, et al. Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. Br J Cancer. 2020.
   Web of Science ®Google Scholar
• Sun P, Song Y, Ruan G, et al. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study. J Gynecol Oncol. 2017;28:e50.28657218
   PubMed Web of Science ®Google Scholar
• Kang WD, Ju UC, Kim SM. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology? Gynecol Oncol. 2018;148:305–310.29183629
   PubMed Web of Science ®Google Scholar
• Silver MI, Andrews J, Cooper CK, et al. Risk of cervical intraepithelial neoplasia 2 or worse by cytology, human papillomavirus 16/18, and colposcopy impression: a systematic review and meta-analysis. Obstet Gynecol. 2018;132:725–735.30095780
   PubMed Web of Science ®Google Scholar